标题
Why imatinib remains an exception of cancer research
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 228, Issue 4, Pages 665-670
出版商
Wiley
发表日期
2012-09-28
DOI
10.1002/jcp.24233
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Karyotype Heterogeneity and Unclassified Chromosomal Abnormalities
- (2013) H.H.Q. Heng et al. CYTOGENETIC AND GENOME RESEARCH
- Heterogeneity of Cell Death
- (2013) J.B. Stevens et al. CYTOGENETIC AND GENOME RESEARCH
- Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials
- (2012) Fausto Petrelli et al. Clinical Lung Cancer
- Genetic and Epigenetic Heterogeneity in Cancer: The Ultimate Challenge for Drug Therapy
- (2012) H. H. Heng et al. CURRENT DRUG TARGETS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Myeloid Leukemia: Current Perspectives
- (2011) Yanming Zhang et al. CLINICS IN LABORATORY MEDICINE
- Monitoring response and resistance to treatment in chronic myeloid leukemia
- (2011) S. Assouline et al. Current Oncology
- Decoding the genome beyond sequencing: The new phase of genomic research
- (2011) Henry H.Q. Heng et al. GENOMICS
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state
- (2011) Tomasz Skorski LEUKEMIA & LYMPHOMA
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diverse system stresses: common mechanisms of chromosome fragmentation
- (2011) J B Stevens et al. Cell Death & Disease
- Cytogenomic aberrations associated with prostate cancer
- (2011) Guangyu Gu et al. Cancer Genetics
- A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer
- (2010) Srikala S. Sridhar et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas
- (2010) Hiroaki Sato et al. BMC CANCER
- Genomic instability and rapid clinical course in adult T-cell lymphoma/leukemia patient
- (2010) Adriana Zámečníkova et al. LEUKEMIA RESEARCH
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lessons from Applied Ecology: Cancer Control Using an Evolutionary Double Bind
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
- (2009) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective
- (2009) Henry H.Q. Heng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Genome based cell population heterogeneity promotes tumorigenicity: The evolutionary mechanism of cancer
- (2009) Christine J. Ye et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history
- (2009) E Jabbour et al. LEUKEMIA
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer
- (2008) G. Gravis et al. ANNALS OF ONCOLOGY
- Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival
- (2008) Nancy P. Caraway et al. CANCER
- A causal role for ERG in neoplastic transformation of prostate epithelium
- (2008) O. Klezovitch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
- (2008) Scott A. Tomlins et al. NEOPLASIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now